4//SEC Filing
ALBANY MOLECULAR RESEARCH INC 4
Accession 0001179110-14-012905
CIK 0001065087operating
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 5:00 PM ET
Size
8.1 KB
Accession
0001179110-14-012905
Insider Transaction Report
Form 4
Nolan Michael M
VP, CFO and Treasurer
Transactions
- Sale
Common Stock
2014-08-14$19.76/sh−10,000$197,600→ 76,093 total - Exercise/Conversion
Option to Purchase Common Stock
2014-08-14$3.43/sh+10,000$34,300→ 75,000 totalExercise: $3.43Exp: 2022-09-17→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2014-08-14$3.43/sh+10,000$34,300→ 86,093 total
Footnotes (1)
- [F1]100% of grant is time based. Time based grant which vests 25% per year on each of the first 4 anniversaries of the date of the grant (September 17, 2012). The 10,000 shares being exercised represent a portion of the vested grant .
Documents
Issuer
ALBANY MOLECULAR RESEARCH INC
CIK 0001065087
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001065087
Filing Metadata
- Form type
- 4
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 5:00 PM ET
- Size
- 8.1 KB